CLTC and cancer: Endocytosis inhibitors such as Wortmannin40 and siRNA targeting clathrin heavy chain significantly reduced HFt transfer, suggesting a role for endocytosis in cancer cell uptake of vesicle-associated HFt (Fig. 6g–k).